(Q70319870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Flecainide versus quinidine: results of a multicenter trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Flecainide versus quinidine: Results of a multicenter trial (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

multicenter clinical trial

8 October 2023

main subject

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

8 October 2023

author name string

M. Hodges

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364770

8 October 2023

D. M. Salerno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364770

8 October 2023

G. Granrud

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6364770

8 October 2023

language of work or name

English

0 references

publication date

1 February 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

27 February 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6364770

full work available at URL

8 October 2023

https://api.elsevier.com/content/article/PII:0002914984905058?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

https://api.elsevier.com/content/article/PII:0002914984905058?httpAccept=text/plain

8 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

American Journal of Cardiology

8 October 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

66B-71B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

Electrophysiological Effects of a New Antiarrhythmic Agent, Flecainide, on the Intact Canine Heart

10 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent

8 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Oral flecainide acetate for the treatment of ventricular arrhythmias

8 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

8 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Clinical pharmacokinetics of antiarrhythmic drugs

8 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial

8 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

8 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine

8 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Effect of tocainide and quinidine on premature ventricular contractions

8 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Disopyramide phosphate: Clinical efficacy of a new oral antiarrhythmie drug

8 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2',6'-propionoxylidide, in man.

8 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes

8 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics

8 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

Antiarrhythmic treatment: An overview

8 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(84)90505-8

8 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6364770%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference